SCHEMBL7450871

SCHEMBL7450871

CCN(CC)c1ccc(C(=O)NCCC(C)CC(=O)NCC#N)cc1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
ESRRG P62508 7/20 0.48
ESRRB O95718 1/20 0.48
ALDH1A1 P00352 2/20 0.45
MAPT P10636 2/20 0.45
KDM4E B2RXH2 1/20 0.45
HTT P42858 1/20 0.45
GFER P55789 1/20 0.41
CNR2 P34972 1/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ADORA2A P29274 1/20 0.38
LMNA P02545 2/20 0.38
POLB P06746 1/20 0.38
GAA P10253 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6182197 0.93 ESRRG (0.46) ESRRGESRRBALDH1A1MAPTKDM4E
SCHEMBL7452250 0.88 HDAC1 (0.49) ALDH1A1KDM4EHTTNPC1RAB9A
SCHEMBL7452326 0.83 SMN1; SMN2 (0.42) NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL6182799 0.83 LMNA (0.45) ESRRGALDH1A1MAPTKDM4ENPC1
SCHEMBL7450457 0.81 MCHR1 (0.43) NPC1RAB9ASMN1; SMN2LMNA
SCHEMBL7554411 0.81 EPHX2 (0.50) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7453120 0.80 NAMPT (0.41) HTTNPC1RAB9ASMN1; SMN2ADORA2A
SCHEMBL6184113 0.80 KDM4E (0.54) KDM4E
SCHEMBL6183529 0.79 ALDH1A1 (0.46) ALDH1A1MAPTNPC1RAB9ASMN1; SMN2
SCHEMBL7449982 0.78 POLB (0.47) ALDH1A1MAPTKDM4EGFERNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1161415-A2 N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-12-12 EP disclosed
WO-2000055126-A2 N-CYANOMETHYLAMIDES AS PROTEASE INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2000-09-21 WO disclosed